Cohort Study | Prognostic model for predicting methotrexate toxicity in immune mediated inflammatory diseases

Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK – The BMJ

News Release: New study reveals way to predict side-effect risk from common immune suppressant medication – University of Nottingham

Commentary: Prognostic model stratifies risk for methotrexate toxicity – ACP Internist